Haemolytic anaemia due to triose phosphate-isomerase deficiency (Q99650): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(One intermediate revision by the same user not shown)
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 16:19, 16 August 2026

Triose-phosphate isomerase deficiency is a severe multisystem inborn error of metabolism characterised by early-onset chronic haemolytic anaemia, always present, and progressive neurological involvement that starts between 6 and 30 months of age. Other clinical signs can be observed, in particular, diaphragm paralysis that requires assisted ventilation, cardiomyopathy and an increased susceptibility to infections.
Language Label Description Also known as
default for all languages
ID_475025488
    English
    Haemolytic anaemia due to triose phosphate-isomerase deficiency
    Triose-phosphate isomerase deficiency is a severe multisystem inborn error of metabolism characterised by early-onset chronic haemolytic anaemia, always present, and progressive neurological involvement that starts between 6 and 30 months of age. Other clinical signs can be observed, in particular, diaphragm paralysis that requires assisted ventilation, cardiomyopathy and an increased susceptibility to infections.

      Statements

      CID11:ID_475025488
      0 references
      dki-india-ID_475025488
      0 references
      Concluído
      0 references
      15 August 2026
      0 references